Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2008
At a glance
- Drugs Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Registrational; Therapeutic Use
- Acronyms CUSTOM-III
- Sponsors Xtent
- 13 Oct 2008 One-year data presented at the Transcatheter Cardiovascular Therapeutics meeting.
- 13 May 2008 Positive six-month follow-up data were presented at the annual EuroPCR meeting in May.
- 25 Oct 2007 New trial record.